Isorhamnetin-3-O-galactoside Protects against CCl4-Induced Hepatic Injury in Mice
Open Access
- 31 July 2012
- journal article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 20 (4), 406-412
- https://doi.org/10.4062/biomolther.2012.20.4.406
Abstract
This study was performed to examine the hepatoprotective effect of isorhamnetin-3-O-galactoside, a flavonoid glycoside isolated from Artemisia capillaris Thunberg (Compositae), against carbon tetrachloride (CCl4)-induced hepatic injury. Mice were treated intraperitoneally with vehicle or isorhamnetin-3-O-galactoside (50, 100, and 200 mg/kg) 30 min before and 2 h after CCl4 (20 μl/kg) injection. Serum aminotransferase activities and hepatic level of malondialdehyde were significantly higher after CCl4 treatment, and these increases were attenuated by isorhamnetin-3-O-galactoside. CCl4 markedly increased serum tumor necrosis factor-α level, which was reduced by isorhamnetin-3-O-galactoside. The levels of inducible nitric oxide synthase (iNOS), cyclooxygenase- 2 (COX-2), and heme oxygenase-1 (HO-1) protein and their mRNA expression levels were significantly increased after CCl4 injection. The levels of HO-1 protein and mRNA expression levels were augmented by isorhamnetin-3-O-galactoside, while isorhamnetin- 3-O-galactoside attenuated the increases in iNOS and COX-2 protein and mRNA expression levels. CCl4 increased the level of phosphorylated c-Jun N-terminal kinase, extracellular signal-regulated kinase and p38, and isorhamnetin-3-O-galactoside reduced these increases. The nuclear translocation of nuclear factor kappa B (NF-κB), activating protein-1, and nuclear factor erythroid 2-related factor 2 (Nrf2) were signifi cantly increased after CCl4 administration. Isorhamnetin-3-O-galactoside attenuated the increases of NF-κB and c-Jun nuclear translocation, while it augmented the nuclear level of Nrf2. These results suggest that isorhamnetin-3-O-galactoside ameliorates CCl4-induced hepatic damage by enhancing the anti-oxidative defense system and reducing the inflammatory signaling pathways.Keywords
This publication has 24 references indexed in Scilit:
- Hepatoprotective Effect of Pinoresinol on Carbon Tetrachloride–Induced Hepatic Damage in MiceJournal of Pharmacological Sciences, 2010
- Postulated Carbon Tetrachloride Mode of Action: A ReviewJournal of Environmental Science and Health, Part C, 2007
- Carbon Monoxide and BilirubinAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Protective Mechanism of Glycyrrhizin on Acute Liver Injury Induced by Carbon Tetrachloride in MiceBiological & Pharmaceutical Bulletin, 2007
- The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activationThe FASEB Journal, 2005
- The aqueous extract from Artemisia capillaris Thunb. inhibits lipopolysaccharide-induced inflammatory response through preventing NF-kappaB activation in human hepatoma cell line and rat liver.2004
- INHIBITORY EFFECT OFARTEMISIA CAPILLARISON ETHANOL-INDUCED CYTOKINES (TNF-α, IL-1α) SECRETION IN HEP G2 CELLSImmunopharmacology and Immunotoxicology, 2002
- Complementary and alternative medicine in chronic liver diseaseHepatology, 2001
- Heme oxygenase: colors of defense against cellular stressAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2000
- Serum and liver concentrations of tumor necrosis factor α and interleukin-1β following administration of carbon tetrachloride to male ratsToxicology Letters, 1998